J P Galanaud

Summary

Country: France

Publications

  1. doi request reprint Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy
    J P Galanaud
    Vascular Medicine Unit, University Hospital, Montpellier, France
    J Thromb Haemost 8:707-13. 2010
  2. doi request reprint The post-thrombotic syndrome: a 2012 therapeutic update
    Jean Philippe Galanaud
    Department of Internal Medicine, Montpellier University Hospital and EA 2992, Montpellier 1 University, Montpellier, France
    Curr Treat Options Cardiovasc Med 15:153-63. 2013
  3. doi request reprint [Epidemiology and management of isolated distal deep venous thrombosis]
    J P Galanaud
    Unité de médecine vasculaire, Departement de Medecine Interne, CHU de Montpellier, 80, avenue Gaston Fliche, 34295 Montpellier Cedex 5, France
    Rev Med Interne 33:678-85. 2012
  4. doi request reprint Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies
    J P Galanaud
    Department of Internal Medicine, Montpellier University Hospital, and Research unit EA 2992, University Montpellier 1, Montpellier, France
    J Thromb Haemost 10:1004-11. 2012
  5. ncbi request reprint Risk factors and early outcomes of patients with symptomatic distal vs. proximal deep-vein thrombosis
    Jean Philippe Galanaud
    Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Grenoble, France
    Curr Opin Pulm Med 17:387-91. 2011
  6. doi request reprint Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study
    Jean Philippe Galanaud
    Centre Hospitalier Universitaire, Vascular Medicine Unit, 34295 Montpellier cedex 05, France
    Thromb Haemost 102:493-500. 2009
  7. doi request reprint Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients
    J P Galanaud
    Vascular Medicine Unit, University Hospital, Montpellier, France
    J Thromb Haemost 7:2028-34. 2009
  8. doi request reprint Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis
    Jean Philippe Galanaud
    Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
    J Vasc Surg 52:932-8, 938.e1-2. 2010
  9. doi request reprint Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study
    Jean Philippe Galanaud
    Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
    Thromb Haemost 105:31-9. 2011
  10. ncbi request reprint [Calf vein thrombosis: to treat or not to treat? Epidemiology, management and problematics]
    J P Galanaud
    Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
    J Mal Vasc 32:225-8. 2007

Detail Information

Publications14

  1. doi request reprint Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy
    J P Galanaud
    Vascular Medicine Unit, University Hospital, Montpellier, France
    J Thromb Haemost 8:707-13. 2010
    ..Half of all venous thromboembolism (VTE) cases during pregnancy are associated with a maternal thrombophilia. The influence of paternal genotype on the placenta and in the genesis of VTE has not been described...
  2. doi request reprint The post-thrombotic syndrome: a 2012 therapeutic update
    Jean Philippe Galanaud
    Department of Internal Medicine, Montpellier University Hospital and EA 2992, Montpellier 1 University, Montpellier, France
    Curr Treat Options Cardiovasc Med 15:153-63. 2013
    ..These techniques are still under evaluation and the level of evidence supporting their use is low...
  3. doi request reprint [Epidemiology and management of isolated distal deep venous thrombosis]
    J P Galanaud
    Unité de médecine vasculaire, Departement de Medecine Interne, CHU de Montpellier, 80, avenue Gaston Fliche, 34295 Montpellier Cedex 5, France
    Rev Med Interne 33:678-85. 2012
    ..Ongoing therapeutic trials should provide important data necessary to establish an evidence-based mode of care, especially about the need to treat distal DVT at low risk of extension with anticoagulants...
  4. doi request reprint Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies
    J P Galanaud
    Department of Internal Medicine, Montpellier University Hospital, and Research unit EA 2992, University Montpellier 1, Montpellier, France
    J Thromb Haemost 10:1004-11. 2012
    ....
  5. ncbi request reprint Risk factors and early outcomes of patients with symptomatic distal vs. proximal deep-vein thrombosis
    Jean Philippe Galanaud
    Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Grenoble, France
    Curr Opin Pulm Med 17:387-91. 2011
    ..Therefore, iDDVT management varies widely from one country/physician to another...
  6. doi request reprint Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study
    Jean Philippe Galanaud
    Centre Hospitalier Universitaire, Vascular Medicine Unit, 34295 Montpellier cedex 05, France
    Thromb Haemost 102:493-500. 2009
    ..Symptomatic isolated distal DVT differs from symptomatic proximal DVT both in terms of risk factors and clinical outcome. Whether these differences should influence the clinical management of these two events remains to be determined...
  7. doi request reprint Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients
    J P Galanaud
    Vascular Medicine Unit, University Hospital, Montpellier, France
    J Thromb Haemost 7:2028-34. 2009
    ..The clinical significance of symptomatic isolated distal deep vein thrombosis (DVT) is uncertain. Consequently, this leads to important disparities in its management...
  8. doi request reprint Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis
    Jean Philippe Galanaud
    Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
    J Vasc Surg 52:932-8, 938.e1-2. 2010
    ..Despite their high prevalence, MCVT and DCVT have never been compared so far, which prevents possible modulation of distal DVT management according to the kind of distal DVT (MCVT or DCVT)...
  9. doi request reprint Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study
    Jean Philippe Galanaud
    Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
    Thromb Haemost 105:31-9. 2011
    ..Larger studies are needed to evaluate predictive factors for adverse outcome...
  10. ncbi request reprint [Calf vein thrombosis: to treat or not to treat? Epidemiology, management and problematics]
    J P Galanaud
    Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
    J Mal Vasc 32:225-8. 2007
    ..CACTUS (compression stocking + placebo versus compression stocking + heparin, for six weeks) that will start in September 2007, should provide answers the following question: should calf vein thrombosis be treated with anticoagulants?..
  11. doi request reprint [Distal deep-venous thrombosis: diagnostic and therapeutic issues]
    I Quere
    Service de Médecine Interne et Maladies Vasculaires, centre hospitalier de Montpellier, 80, avenue Gaston Fliche, 34295 Montpellier Cedex 5, France
    Rev Med Interne 29:491-7. 2008
    ..Compression ultrasonography is the reference test for the diagnosis of distal deep venous thrombosis of lower limbs. However, the ways it is performed and the related treatments are very heterogeneous between various countries...
  12. doi request reprint [Prevalence and risk factors of peripheral arterial disease in an outpatient screening campaign]
    T Behar
    EA 2992, Service de Medecine Vasculaire, Departement de Medecine Interne, CHU de Montpellier, Universite Montpellier 1, 80, avenue Augustin Fliche, 34295 Montpellier Cedex 5, France
    J Mal Vasc 38:22-8. 2013
    ..Peripheral arterial disease (PAD) is an important predictor of cardiovascular disease with major medico-economic consequences. However, systematic screening of asymptomatic patients free from history of cardiovascular disease is debated...
  13. ncbi request reprint Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis
    J P Galanaud
    Clinical Investigation Center and Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
    J Thromb Haemost 12:436-43. 2014
    ..Its clinical significance and management are controversial. Data on long-term follow-up are scarce, especially concerning risk and predictors of venous thromboembolism (VTE) recurrence...
  14. doi request reprint The history and historical treatments of deep vein thrombosis
    J P Galanaud
    Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
    J Thromb Haemost 11:402-11. 2013
    ..In these times of change regarding DVT treatment, mainly marked by the arrival of new oral anticoagulants, efforts of physicians through the ages to treat this common disease provide a beautiful example of the history of knowledge...